BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
Saved in:
| Title: | BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors. |
|---|---|
| Authors: | Petrelli A; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Rizzolio S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bellomo SE; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Benelli M; Bioinformatics Unit, Oncology Department, Nuovo Ospedale-Santo Stefano, Prato, Italy., De Cecco L; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Romagnoli D; Bioinformatics Unit, Oncology Department, Nuovo Ospedale-Santo Stefano, Prato, Italy., Berrino E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Medical Sciences, University of Torino, Torino, Italy., Orrù C; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Ribisi S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Moya-Rull D; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Migliore C; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Conticelli D; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Maina IM; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Puliga E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Pellegrino B; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy., Llop-Guevara A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Musolino A; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy., Siena S; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Sartore-Bianchi A; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Prisciandaro M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy., Morano F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Antista M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fumagalli U; Digestive Surgery, European Institute of Oncology, IRCCS, Milan, Italy., De Manzoni G; Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Section of Surgery, University of Verona, Verona, Italy., Degiuli M; Department of Oncology, University of Torino, Orbassano, Italy., Baiocchi GL; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Amisano MF; Department of Surgery, Santo Spirito Hospital, ASL-AL, Rome, Italy., Ferrero A; General and Oncological Surgery, Mauriziano Hospital, Torino, Italy., Marchiò C; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Medical Sciences, University of Torino, Torino, Italy., Corso S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Giordano S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy. |
| Source: | Cancer research [Cancer Res] 2023 May 15; Vol. 83 (10), pp. 1699-1710. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
